Q-omics provides the consensus-scored MIR6868 profile across patient tissues and cancer cell-line models. MIR6868 expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in LIHC. Additionally, MIR6868 RNA expression shows 4,434 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LIHC, and STAD as cancer lineages where MIR6868 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MIR6868 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MIR6868 survival associations across molecular data types. MIR6868 RNA expression shows survival associations in the most cancer types (6). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MIR6868 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	6	LIHC (90)	view →

This table ranks reproducible MIR6868 RNA expression–survival associations across cancer types. High MIR6868 expression shows unfavorable associations in LIHC, THCA, BLCA, SKCM, SARC and LUAD. The LIHC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LIHC as the clearest survival context for MIR6868 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.093	0.783	<.001	90	view →
THCA	OS	Tertile	II,III,IV	0.173	0.903	<.001	72	view →
BLCA	OS	Tertile	III,IV	0.082	0.582	<.001	36	view →
SKCM	OS	Tertile	All	0.143	0.343	.030	27	view →
SARC	DFS	Tertile	All	0.147	0.518	.012	21	view →
LUAD	OS	Tertile	III,IV	0.223	0.677	.006	18	view →

Pink = unfavorable, green = favorable. all 6 lineages →

MIR6868-LIHC (OS)

Kaplan–Meier survival curve for MIR6868 RNA expression in LIHC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MIR6868 in patient tissues and cancer cell lines. In patient samples, MIR6868 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	4,434	STAD (3237)	view →
Protein (mass-spec)	2,359	LSCC (765)	view →